Tau or neurofilament light—Which is the more suitable biomarker for Huntington’s disease? - Niemelä, Valter; Landtblom, Anne-Marie; Blennow, Kaj; Sundblom, Jimmy (PloS one, 2017)
Keywords: Adult; Aged; Alzheimer's disease; Alzheimers disease; Axons - metabolism; Biological markers; Biology and Life Sciences; Biomarkers; Biomarkers - cerebrospinal fluid; Brain research; care; Care and treatment; Cerebrospinal fluid; cerebrospinal-fluid biomarkers; Clinical trials; Cohort Studies; Correlation; csf; Cytoplasmic filaments; Diagnosis; Disease control; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Genetic aspects; Humans; Huntington Disease - cerebrospinal fluid; Huntington Disease - diagnosis; Huntington Disease - genetics; Huntington's disease; Huntingtons disease; Light; Light levels; Male; Medicine and Health Sciences; Middle Aged; Multiple sclerosis; Mutation; natural-history; Neurochemistry; Neurodegeneration; Neurofilament Proteins - cerebrospinal fluid; Neurologi; Neurology; Neurosciences; Neurovetenskaper; pathology; Physiological aspects; protein; Proteins; Science & Technology - Other Topics; Studies; Tau protein; Tau proteins; tau Proteins - cerebrospinal fluid; Young Adult